Skip to main content


Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 2 Total score of Treatment Satisfaction Questionnaire for Medication (TSQM-9)

From: Real world experience of patients with amyotrophic lateral sclerosis (ALS) in the treatment of spasticity using tetrahydrocannabinol:cannabidiol (THC:CBD)

Questions Q 1 Q 2 Q3 Q4 Q5 Q6 Q7 Q8 Q9
Mean Score 73.5 71.9 66.2 65.6 87.5 76.6 72.7 71.1 79.2
STD 24.6 26.2 24.1 38.6 20.3 32.5 29. 3 33.7 22.8
  1. The patients’ treatment satisfaction with THC:CBD, as assessed by Treatment Satisfaction Questionnaire for Medication (TSQM-9). The score was evaluated separately in nine questions. Each of the nine questions is evaluated in a total score that can range from 0 to 100. A higher total score equates to greater satisfaction. Question (Q) 1 – ability of THC:CBD to prevent or treat spasticity; Q 2 – the way THC:CBD relieves spasticity; Q 3 – amount of time it takes THC:CBD to start working; Q4 – usability of THC:CBD; Q 5 – planning when to use THC:CBD; Q 6 – administration of THC:CBD as instructed; Q 7 – taking THC:CBD is a good thing; Q 8 – the good things about THC:CBD outweigh the bad things; Q 9 – overall satisfaction THC:CBD; n number of patients. STD standard deviation